| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2020 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,159 | $22.33 | $70,551.84 | -6.3% | |
| Feb 18, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 10,000 | $21.64 | $216,390.00 | -5.6% | |
| Jan 17, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 10,000 | $19.59 | $195,930.50 | -5.3% | |
| Jan 15, 2020 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 6,318 | $19.85 | $125,423.85 | -6.1% | |
| Dec 16, 2019 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $18.69 | $46,725.00 | -11.5% | |
| Nov 21, 2019 | Lanfear Dennis M | President &CEO | Sell | 12,500 | $18.56 | $231,960.00 | -2.7% | |
| Nov 20, 2019 | Lanfear Dennis M | President &CEO | Sell | 825,000 | $18.00 | $14,850,000.00 | -64.2% | |
| Nov 20, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,159 | $19.59 | $61,871.86 | -48.9% | |
| Nov 18, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sell | 3,112 | $18.88 | $58,757.36 | -48.5% | |
| Nov 14, 2019 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $19.26 | $48,150.00 | -11.5% |